Global Nutrition Target Collaborators. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Arndt, Michael Benjamin; Bhattacharjee, Natalia V.; Chalek, Julian; Kisa, Adnan; Farmer, Sam; Fitzgerald, Ryan; Kisa, Sezer; Gardner, William M.; Gakidou, Emmanuela; Nutrition Targets Collaborator, GBD 2021 Global
Peer reviewed, Journal article
Published version
Date
2024Metadata
Show full item recordCollections
Abstract
Background The six global nutrition targets (GNTs) related to low birthweight, exclusive breastfeeding, child growth (ie, wasting, stunting, and overweight), and anaemia among females of reproductive age were chosen by the World Health Assembly in 2012 as key indicators of maternal and child health, but there has yet to be a comprehensive report on progress for the period 2012 to 2021. We aimed to evaluate levels, trends, and observed-to-expected progress in prevalence and attributable burden from 2012 to 2021, with prevalence projections to 2050, in 204 countries and territories.
Methods The prevalence and attributable burden of each target indicator were estimated by age group, sex, and year in 204 countries and territories from 2012 to 2021 in the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, the most comprehensive assessment of causes of death, disability, and risk factors to date. Country-specific relative performance to date was evaluated with a Bayesian meta-regression model that compares prevalence to expected values based on Socio-demographic Index (SDI), a composite indicator of societal development status. Target progress was forecasted from 2021 up to 2050 by modelling past trends with meta-regression using a combination of key quantities and then extrapolating future projections of those quantities.
Findings In 2021, a few countries had already met some of the GNTs: five for exclusive breastfeeding, four for stunting, 96 for child wasting, and three for child overweight, and none met the target for low birthweight or anaemia in females of reproductive age. Since 2012, the annualised rates of change (ARC) in the prevalence of child overweight increased in 201 countries and territories and ARC in the prevalence of anaemia in females of reproductive age decreased considerably in 26 countries. Between 2012 and 2021, SDI was strongly associated with indicator prevalence, apart from exclusive breastfeeding (|r-|=0·46–0·86). Many countries in sub-Saharan Africa had a decrease in the prevalence of multiple indicators that was more rapid than expected on the basis of SDI (the differences between observed and expected ARCs for child stunting and wasting were –0·5% and –1·3%, respectively). The ARC in the attributable burden of low birthweight, child stunting, and child wasting decreased faster than the ARC of the prevalence for each in most low-income and middle-income countries. In 2030, we project that 94 countries will meet one of the six targets, 21 countries will meet two targets, and 89 countries will not meet any targets. We project that seven countries will meet the target for exclusive breastfeeding, 28 for child stunting, and 101 for child wasting, and no countries will meet the targets for low birthweight, child overweight, and anaemia. In 2050, we project that seven additional countries will meet the target for exclusive breastfeeding, five for low birthweight, 96 for child stunting, nine for child wasting, and one for child overweight, and no countries are projected to meet the anaemia target.
Interpretation Based on current levels and past trends, few GNTs will be met by 2030. Major reductions in attributable burden for exclusive breastfeeding and anthropometric indicators should be recognised as huge scientific and policy successes, but the comparative lack of progress in reducing the prevalence of each, along with stagnant anaemia in women of reproductive age and widespread increases in child overweight, suggests a tenuous status quo. Continued investment in preventive and treatment efforts for acute childhood illness is crucial to prevent backsliding. Parallel development of effective treatments, along with commitment to multisectoral, long-term policies to address the determinants and causes of suboptimal nutrition, are sorely needed to gain ground.
Journal
The LancetRelated items
Showing items related by title, author, creator and subject.
-
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019
Ledesma, Jorge R; Ma, Jianing; Vongpradith, Avina; Maddison, Emilie R.; Biehl, Molly H; LeGrand, Kate E.; Kisa, Adnan; Ross, Jennifer M.; Jahagirdar, Deepa; Kisa, Sezer; Bryazka, Dana; Feldman, Rachel; Murray, Christopher J L; Kyu, Hmwe Hmwe; Tuberculosis Collaborators, GBD 2019 (The Lancet Infectious Diseases;, Peer reviewed; Journal article, 2021-09-23)Background: Tuberculosis is a major contributor to the global burden of disease, causing more than a million deaths annually. Given an emphasis on equity in access to diagnosis and treatment of tuberculosis in global health ... -
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study
James, Spenser L.; Castle, Chris D.; Dingels, Zachary V.; Fox, Jack T.; Kisa, Adnan; Kisa, Sezer; Vos, Theo; Reiner, Robert C. (Injury Prevention;Volume 26, Issue Supp 1, Journal article; Peer reviewed, 2020-08-24)Background: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates ... -
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
Kisa, Sezer (Lancet Oncology;Volume 20, Issue 9, Journal article; Peer reviewed, 2019)Background Accurate childhood cancer burden data are crucial for resource planning and health policy prioritisation. Model-based estimates are necessary because cancer surveillance data are scarce or non-existent in many ...